- Home
- CNTA vs WTM Comparison
CNTA vs WTM Comparison
Compare CNTA & WTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | WTM |
|---|---|---|
| Founded | 2020 | 1980 |
| Country | United Kingdom | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.5B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CNTA | WTM |
|---|---|---|
| Price | $39.50 | $2,267.00 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $43.17 | N/A |
| AVG Volume (30 Days) | ★ 4.9M | 12.1K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.04% |
| EPS Growth | 29.13 | ★ 379.05 |
| EPS | N/A | ★ 430.14 |
| Revenue | $15,000,000.00 | ★ $3,735,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.28 |
| Revenue Growth | N/A | ★ 66.76 |
| 52 Week Low | $10.95 | $1,648.00 |
| 52 Week High | $40.26 | $2,333.00 |
Technical Indicators
Market Signals| Indicator | CNTA | WTM |
|---|---|---|
| Relative Strength Index (RSI) | 73.71 | 52.29 |
| Support Level | $39.16 | $2,012.62 |
| Resistance Level | $40.26 | $2,329.39 |
| Average True Range (ATR) | 0.22 | 42.04 |
| MACD | -0.45 | -5.36 |
| Stochastic Oscillator | 52.34 | 19.16 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About WTM White Mountains Insurance Group Ltd.
White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.